HEPATIC STEATOSIS
Clinical trials for HEPATIC STEATOSIS explained in plain language.
Never miss a new study
Get alerted when new HEPATIC STEATOSIS trials appear
Sign up with your email to follow new studies for HEPATIC STEATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Timing your meals and exercise may shrink fatty liver, study finds
Disease control CompletedThis study looked at whether eating only during a set window each day (time-restricted eating) combined with supervised exercise can reduce liver fat and improve heart health in adults with obesity. 187 people took part in a 12-week program. The goal was to see if combining these…
Matched conditions: HEPATIC STEATOSIS
Phase: NA • Sponsor: Universidad de Granada • Aim: Disease control
Last updated May 26, 2026 09:04 UTC
-
New fatty liver drug tested in humans for first time
Knowledge-focused CompletedThis early-stage study tested a new medicine called NNC0581-0001 in 48 adults to see if it is safe and how the body handles it. Some participants were healthy, and others had fatty liver (hepatic steatosis). Each person received either one injection of the drug or a placebo. The …
Matched conditions: HEPATIC STEATOSIS
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated May 26, 2026 08:56 UTC
-
Teens' liver health after weight-loss surgery: a closer look
Knowledge-focused CompletedThis study looked at 20 obese teenagers (ages 13-20) who were scheduled for bariatric surgery. Researchers measured liver fat and how the body processes energy before and one year after surgery. The goal was to understand how the surgery affects liver health and metabolism, not t…
Matched conditions: HEPATIC STEATOSIS
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated May 26, 2026 08:54 UTC
-
Hormone therapy may improve liver fat in menopause, small study suggests
Knowledge-focused CompletedThis study looked at whether menopausal hormone therapy (MHT) helps liver function and reduces fatty liver in postmenopausal women. 44 women were split into two groups: 22 received MHT and 22 did not. After 6 months, researchers measured liver fat, enzymes, and fibrosis risk usin…
Matched conditions: HEPATIC STEATOSIS
Phase: NA • Sponsor: Ipek B. Ozcivit Erkan, MD • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC